Cash Flow from Operating Activities: A company's cash flows from operations.
Pelthos Therapeutics Inc. (PTHS) had Cash Flow from Operating Activities of $-20.79M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$15.60M |
|
$-23.42M |
|
$3.61M |
|
$11.99M |
|
$32.93M |
|
$-17.32M |
|
$-6.09M |
|
$-23.42M |
|
$-23.42M |
|
$-23.42M |
|
$-23.42M |
|
$-23.42M |
|
$-23.42M |
|
$-17.32M |
|
$-15.70M |
|
3.54M |
|
3.54M |
|
$-6.62 |
|
$-6.62 |
|
| Balance Sheet Financials | |
$63.36M |
|
$8.88M |
|
$74.00M |
|
$137.36M |
|
$31.96M |
|
$69.91M |
|
$106.90M |
|
$138.86M |
|
$-1.50M |
|
$-63.58M |
|
$-1.50M |
|
3.72M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-20.79M |
$-0.20M |
|
$27.52M |
|
$18.02M |
|
$24.56M |
|
$6.54M |
|
$4.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.98 |
|
-- |
|
-- |
|
1.02 |
|
-46.58 |
|
76.86% |
|
-111.02% |
|
-111.02% |
|
-- |
|
-150.08% |
|
-150.08% |
|
$-20.99M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.17 |
|
1.08 |
|
83.53 |
|
1560.10% |
|
36.83% |
|
-17.05% |
|
-34.23% |
|
$-0.40 |
|
$-5.93 |
|
$-5.87 |
|